The Europe neurotoxins market is expected to grow from US$ 1,174.94 million in 2023 to US$ 2,038.94 million by 2028. It is estimated to register a CAGR of 11.7% from 2022 to 2028.

Surge in Cosmetic Procedures to Improve Appearance Fuels Europe Neurotoxins Market

Structural changes affecting the skin, muscles, ligaments, fat, and bone get noticeable on an individual’s face due to decrease in cellular functions with aging. The inevitable physiological process of aging is generally not conceived positively by many, which, in turn, urges them to indulge in cosmetic rejuvenation procedures to remain youthful visually. Botulinum toxin (BOTA) is the most popular neurotoxin used in cosmetic procedures. The BOTA selection to treat the aforementioned case involved Abobotulinum A (ABO; Dysport/Ipsen Limited, Slough Berkshire, UK) containing 500 European units. Following the manufacturer’s recommended ratio of 2.5 ml saline solution to 500 units botulinum toxin was administered, the reconstitution was carried out. Therefore, the rising popularity of cosmetic procedures involving neurotoxins to reduce facial wrinkles while ensuring safety, effectivity, and efficiency is catalyzing the market for neurotoxins.

Europe Neurotoxins Market Overview

The Europe neurotoxin market has been segmented into the UK, Germany, France, Italy, Spain, Poland, Russia, and the Rest of Europe. The surging geriatric population, rising product launches, increasing distribution of neurotoxin products, and growing government regulations for non-surgical aesthetic products and procedures will likely enhance the market growth. Also, rising numbers of aesthetic clinics may offer vital growth opportunities for market growth. In the UK, there was no industry to regulate the standards for non-surgical procedures. Also, there was no need for a legal license to perform Botox or filler injections procedures. Thus, these were the leading factors that defined the growth of the neurotoxin market in the past few years across the country. However, in 2013, Health Education England developed standards and qualifications frameworks for practitioners’ failings to improve public protection and to reduce risks that may cause severe side effects of aesthetic procedures.

Exhibit: Europe Neurotoxins Market Revenue and Forecast to 2028 (US$ Million)

Europe Neurotoxins Market Segmentation

The Europe neurotoxins market is segmented into product type, application, end user, and country.

Based on product type, the Europe neurotoxins market is subsegmented into botox, dysport, xenomin, and others, dysport, xenomin, and others. The botox segment registered the largest market share in 2023.

Based on application, the Europe neurotoxins market is segmented into therapeutic and aesthetic. The therapeutic segment held a larger market share in 2023.

Based on end user, the market is segmented into hospitals, specialty clinics, dermatology clinics, and others. The hospitals segment held the largest market share in 2023.

Based on country, the market is segmented into the UK, Germany, France, Italy, Spain, Poland, Russia, and the Rest of Europe. Germany dominated the market share in 2023.

AbbVie Inc, Evolus Inc, Hugel Inc, Ipsen SA, Medytox Inc, and Merz Pharma GmbH & Co KGaA are among the leading companies operating in the Europe neurotoxins market.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Neurotoxin Market – by Type
1.3.2 Europe Neurotoxin Market – by Application
1.3.3 Europe Neurotoxin Market – by End User
1.3.4 Europe Neurotoxin Market – by Country
2. Europe Neurotoxin Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Neurotoxin Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert Opinion
5. Europe Neurotoxin Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Surge in Cosmetic Procedures to Improve Appearance
5.1.2 Emergence of Innovative Facial Aesthetic Products
5.2 Market Restraints
5.2.1 Improper/Inappropriate Injection Technique
5.3 Future Trends
5.3.1 BOTA for Assisted Reproductive Technology (ART)
5.4 Impact Analysis
6. Europe Neurotoxin Market
6.1 Europe Neurotoxin Market Revenue Forecast and Analysis
7. Europe Neurotoxin Market – Revenue and Forecast to 2028 – By Type
7.1 Overview
7.2 Europe Neurotoxin Market Revenue Share, by Type (2022 and 2028)
7.3 Botox
7.3.1 Overview
7.3.2 Botox: Europe Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Dysport
7.4.1 Overview
7.4.2 Dysport: Europe Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Xeomin
7.5.1 Overview
7.5.2 Xeomin: Europe Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Europe Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Neurotoxin Market – Revenue and Forecast to 2028 – By Application
8.1 Overview
8.2 Europe Neurotoxin Market Revenue Share, by Application (2022 and 2028)
8.3 Therapeutic
8.3.1 Overview
8.3.2 Therapeutic: Europe Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Aesthetic
8.4.1 Overview
8.4.2 Aesthetic: Europe Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Neurotoxin Market – Revenue and Forecast to 2028 – By End User
9.1 Overview
9.2 Europe Neurotoxin Market Revenue Share, by End User (2022and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Europe Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Medical Spas and Beauty Centers
9.4.1 Overview
9.4.2 Medical Spas and Beauty Centers: Europe Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Dermatology Clinics
9.5.1 Overview
9.5.2 Dermatology Clinics: Europe Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Europe Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Neurotoxin Market -Revenue and Forecast to 2028- Country Analysis
10.1 Overview
10.1.1 Europe: Neurotoxin Market, by Country, 2022 & 2028 (%)
10.1.1.1 UK: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 UK: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 UK: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.1.1.4 UK: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.1.1.5 UK: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.1.2 Germany: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Germany: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Germany: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.1.2.4 Germany: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.1.2.5 Germany: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.1.3 France: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 France: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 France: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.1.3.4 France: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.1.3.5 France: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.1.4 Italy: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Italy: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.1.4.4 Italy: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.1.4.5 Italy: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.1.5 Spain: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 Spain: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.1.5.4 Spain: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.1.5.5 Spain: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.1.6 Poland: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Poland: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Poland: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.1.6.4 Poland: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.1.6.5 Poland: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.1.7 Russia: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.7.1 Overview
10.1.1.7.2 Russia: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.7.3 Russia: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.1.7.4 Russia: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.1.7.5 Russia: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
10.1.1.8 Rest of Europe: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.8.1 Overview
10.1.1.8.2 Rest of Europe: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.8.3 Rest of Europe: Neurotoxin Market, by Product Type, 2020-2028 (US$ Million)
10.1.1.8.4 Rest of Europe: Neurotoxin Market, by Application, 2020-2028 (US$ Million)
10.1.1.8.5 Rest of Europe: Neurotoxin Market, by End User, 2020-2028 (US$ Million)
11. Europe Neurotoxins Market-Industry Landscape
11.1 Overview
11.2 Organic Growth Strategies
11.2.1 Overview
11.3 Inorganic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Merz Pharma GmbH & Co KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 AbbVie Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Ipsen SA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Medytox Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Evolus Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 1SWOT Analysis
12.5.6 Key Developments
12.6 Hugel Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Europe Neurotoxins Market – Revenue and Forecast to 2028 (US$ Million)
Table 2. UK Neurotoxin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. UK Neurotoxin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. UK Neurotoxin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. Germany: Neurotoxin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. Germany: Neurotoxin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 7. Germany: Neurotoxin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 8. France: Neurotoxin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 9. France: Neurotoxin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 10. France: Neurotoxin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. Italy: Neurotoxin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. Italy: Neurotoxin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 13. Italy: Neurotoxin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 14. Spain: Neurotoxin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 15. Spain: Neurotoxin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Spain: Neurotoxin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Poland: Neurotoxin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Poland: Neurotoxin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 19. Poland: Neurotoxin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 20. Russia: Neurotoxin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 21. Russia: Neurotoxin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 22. Russia: Neurotoxin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of Europe: Neurotoxin Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 24. Rest of Europe: Neurotoxin Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 25. Rest of Europe: Neurotoxin Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 26. Recent Organic Growth Strategies in Neurotoxins Market
Table 27. Recent Inorganic Growth Strategies in the Neurotoxins Market
Table 28. Glossary of Terms

LIST OF FIGURES

Figure 1. Europe Neurotoxin Market Segmentation
Figure 2. Europe Neurotoxin Market by Country
Figure 3. Europe Neurotoxin Market Overview
Figure 4. Europe Neurotoxin Market, By Type
Figure 5. Europe Neurotoxin Market, By Country
Figure 6. Europe: PEST Analysis
Figure 7. Europe Neurotoxin Market: Impact Analysis of Drivers and Restraints
Figure 8. Europe Neurotoxin Market – Revenue Forecast and Analysis – 2021-2028
Figure 9. Europe Neurotoxin Market Revenue Share, by Type (2022 and 2028)
Figure 10. Botox: Europe Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Dysport: Europe Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Xeomin: Europe Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Others: Europe Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Neurotoxin Market Revenue Share, by Application (2022 and 2028)
Figure 15. Therapeutic: Europe Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Aesthetic: Europe Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Europe Neurotoxin Market Revenue Share, by End User (2022 and 2028)
Figure 18. Hospitals: Europe Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Medical Spas and Beauty Centers: Europe Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Dermatology Clinics: Europe Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Europe Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Europe: Neurotoxin Market, by Key Country – Revenue (2022) (US$ Million)
Figure 23. Europe: Neurotoxin Market, by Country, 2022 & 2028 (%)
Figure 24. UK: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Germany: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. France: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Italy: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Spain: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Poland: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Russia: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Rest of Europe: Neurotoxin Market – Revenue and Forecast to 2028 (US$ Million)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe neurotoxins market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the Europe neurotoxins market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the neurotoxins market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

The List of Companies – Europe Neurotoxins Market

● AbbVie Inc
● Evolus Inc
● Hugel Inc
● Ipsen SA
● Medytox Inc
● Merz Pharma GmbH & Co KGaA